Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies ...Middle East

PETACH TIKVA, Israel, April 16, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today announced a research collaboration with Daiichi Sankyo (TSE: 4568) through its Daiichi Sankyo...

Hence then, the article about interna therapeutics announces research collaboration with daiichi sankyo to advance mnm based targeted delivery technologies was published today ( Thursday 16/04/2026 - 12:50 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies )

Also on site :

• Best-Selling Author’s Novel Named Among ‘Best Books of All Time’
• Target's 'Really Cute' Accent Table Is Giving Massive West Elm Vibes for Way Less
• All of Prince Harry’s Candid Quotes About ‘Messy’ Dad Life During Australian Tour